The Impact of a Nutritional Intervention on Glycemic Control and Cardiovascular Risk Markers in Type 2 Diabetes
TP Minari, CF Manzano, LHB Tácito, LBT Yugar… - Nutrients, 2024 - mdpi.com
Introduction: Nutritional management plays a crucial role in treating patients with type 2
diabetes (T2D), working to prevent and control the progression of chronic non …
diabetes (T2D), working to prevent and control the progression of chronic non …
The Emerging Role of Prediabetes and Its Management: Focus on l-Arginine and a Survey in Clinical Practice
The worldwide impressive growth of metabolic disorders observed in the last decades,
especially type 2 diabetes mellitus and obesity, has generated great interest in the potential …
especially type 2 diabetes mellitus and obesity, has generated great interest in the potential …
The Renoprotective Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i)—A Narrative Review
L Iordan, L Gaita, R Timar, V Avram, A Sturza… - International Journal of …, 2024 - mdpi.com
Chronic kidney disease (CKD) is a noncommunicable condition that has become a major
healthcare burden across the globe, often underdiagnosed and associated with low …
healthcare burden across the globe, often underdiagnosed and associated with low …
[HTML][HTML] The impact of diabetes mellitus on the outcome of troponin-positive patients with non-obstructive coronary arteries
F Kreimer, C Schlettert, M Abumayyaleh, I Akin… - IJC Heart & …, 2024 - Elsevier
Background Diabetes mellitus is a major cardiovascular risk factor for the development of
coronary artery disease, but knowledge about the impact of diabetes mellitus on the …
coronary artery disease, but knowledge about the impact of diabetes mellitus on the …
[HTML][HTML] Diretriz Brasileira de Ergometria em População Adulta–2024
T Carvalho, OGA Freitas, WA Chalela… - Arquivos Brasileiros …, 2024 - SciELO Brasil
Diretriz Brasileira de Ergometria em População Adulta–2024 O relatório abaixo lista as
declarações de interesse conforme relatadas à SBC pelos especialistas durante o período …
declarações de interesse conforme relatadas à SBC pelos especialistas durante o período …
Long-term effects of different hypoglycemic drugs on carotid intima-media thickness progression: a systematic review and network meta-analysis
Q Lv, Y Yang, Y Lv, Q Wu, X Hou, L Li, X Ye… - Frontiers in …, 2024 - frontiersin.org
Objective The progression of carotid intima-media thickness (cIMT) can partially predict the
occurrence of future cardiovascular events. This network meta-analysis compared the effects …
occurrence of future cardiovascular events. This network meta-analysis compared the effects …
Sex differences in clinical profile, left ventricular remodeling and cardiovascular outcomes among diabetic patients with heart failure and reduced ejection fraction: a …
K Shi, G Zhang, H Fu, XM Li, L Jiang, Y Gao… - Cardiovascular …, 2024 - Springer
Background Heart failure with reduced ejection fraction (HFrEF) is associated with a high
rate of mortality and morbidity. Evidence has shown that sex differences may be an …
rate of mortality and morbidity. Evidence has shown that sex differences may be an …
Research advances in the anti-inflammatory effects of SGLT inhibitors in type 2 diabetes mellitus
R Zhang, Q Xie, X Lu, R Fan, N Tong - Diabetology & Metabolic Syndrome, 2024 - Springer
Diabetes mellitus is one of the most significant global burden diseases. It is well established
that a chronic, systemic, low-grade inflammatory condition is strongly correlated with type 2 …
that a chronic, systemic, low-grade inflammatory condition is strongly correlated with type 2 …
Incident Cardiovascular Disease in Women With Type 1 or Type 2 Diabetes Following a Hypertensive Disorder of Pregnancy
K Mattsson, M Pihlsgård, S Enhörning, S Timpka - Hypertension, 2024 - Am Heart Assoc
BACKGROUND: The extent to which a history of hypertensive disorders of pregnancy is
associated with incident cardiovascular disease also among women with diabetes is …
associated with incident cardiovascular disease also among women with diabetes is …
ProtecT-2-D trial protocol: cardiovascular protection in patients with type 2 diabetes and established heart and/or vascular disease at a cardio-metabolic clinic—a …
KS Overgaard, RA Mohamed, TR Andersen… - Cardiovascular …, 2024 - Springer
Background Cardiovascular disease remains the primary cause of morbidity and mortality
despite advancements in the treatment of patients with type 2 diabetes. Effective diabetes …
despite advancements in the treatment of patients with type 2 diabetes. Effective diabetes …